Cepheid Share Price

Stocks

01/12/01

15/17/15	Cepheid : Announces FDA Clearance Of Xpert® Xpress Flu And Xpert Xpress Flu/RSV	PU
05/16/05	Cepheid : Danaher Completes Acquisition Of Cepheid	PR
27/16/27	Cepheid : 30 Minute Or Less Molecular Flu/RSV Test Now Available Outside The US	PR
24/16/24	Cepheid : Announces Receipt of Required Regulatory Clearances in Proposed Acquisition by Danaher Corporation	PR
06/16/06	Cepheid : New Bladder Cancer Test Could Reduce Number Of Invasive Procedures Required For Recurrence Monitoring	PR

06/16/06	Danaher : renforce dans les diagnostics avec Cepheid
06/16/06	Danaher : acquiert le spécialiste des diagnostics Cepheid

Manager	Title	Age	Since
Charles Mwangi DFI	Director of Finance/CFO	59	01/07/2023
Anupama Mokkapati COO	Chief Operating Officer	-	01/11/2021
Laurent Bellon COO	Chief Operating Officer	-	01/08/2018

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CEPHEID	-.--%	+0.36%	-	-	0
SARTORIUS AG	+3.78%	+2.39%	+15.86%	-39.35%	1.57TCr
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+1.77%	+9.36%	-0.04%	+98.18%	174.45Cr
QUIDELORTHO CORPORATION	-0.95%	+1.46%	-36.11%	-80.87%	113.67Cr
ECKERT & ZIEGLER SE	+1.71%	-2.42%	-38.33%	+13.14%	98Cr
CONTEC MEDICAL SYSTEMS CO.,LTD	+0.28%	+0.38%	-45.34%	-54.13%	63Cr
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	+1.36%	+0.15%	-47.70%	-57.13%	52Cr
VAREX IMAGING CORPORATION	+1.37%	+3.82%	+40.89%	-51.71%	47Cr
REVENIO GROUP OYJ	+1.31%	-0.32%	-56.18%	-60.88%	38Cr
CELLAVISION AB	+1.83%	-0.28%	-20.04%	-34.81%	36Cr
Average	+0.47%	+1.72%	-20.78%	-29.73%	243.36Cr
Weighted average by Cap.	-0.24%	+2.42%	+4.93%	-29.62%